Literature DB >> 22143478

Metastatic melanoma to the intracavitary left ventricle treated using cardiac autotransplantation technique for resection.

Monika J Leja1, Min Kim, Lynda Perryman, Shanda H Blackmon, Michael J Reardon.   

Abstract

Melanoma has a known propensity for cardiac metastasis. Most cases are associated with widespread metastatic disease and multiple sites of cardiac involvement and are not appropriate for surgical resection. When there is an isolated metastasis to the heart, the melanoma tends to involve the right heart. Rarely does melanoma metastasize only to the left ventricle. We present an unusual case of isolated metastasis of melanoma to the intracavitary left ventricle. This tumor was poorly responsive to chemotherapy, and a cardiac autotransplantation technique was used to achieve complete resection with pathologically negative margins.

Entities:  

Mesh:

Year:  2011        PMID: 22143478     DOI: 10.14797/mdcj-7-4-44

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  4 in total

1.  The Current Role of Surgery in the Treatment of Cardiac Metastases from Malignant Melanoma: an Educational Presentation.

Authors:  Kyriakos Spiliopoulos; Peter Engels; Konstantina Kimpouri; Iraklis Floudas; Nikolaos S Salemis; Franz-Xaver Schmid
Journal:  Braz J Cardiovasc Surg       Date:  2021-02-01

2.  BRAFV600E-mutant melanoma presenting with cardiac involvement.

Authors:  Douglas B Johnson; Jeffrey A Sosman
Journal:  J Natl Compr Canc Netw       Date:  2014-05       Impact factor: 11.908

Review 3.  Evaluation and Management of Cardiac Tumors.

Authors:  Nicolas Palaskas; Kara Thompson; Gregory Gladish; Ali M Agha; Saamir Hassan; Cezar Iliescu; Peter Kim; Jean B Durand; Juan C Lopez-Mattei
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-20

Review 4.  Surgical management of the patient with metastatic melanoma to the heart.

Authors:  Joshua M Judge; John D Tillou; Craig L Slingluff; John A Kern; Irving L Kron; Geoffrey R Weiss
Journal:  J Card Surg       Date:  2013-02-13       Impact factor: 1.620

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.